JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totaling 520,831 shares, an increase of 100.3% from the June 30th total of 260,076 shares. Based on an average trading volume of 95 shares, the short-interest ratio is currently 5,482.4 days.

JCR Pharmaceuticals Price Performance

Shares of JCR Pharmaceuticals stock remained flat at $3.31 during trading hours on Friday. JCR Pharmaceuticals has a twelve month low of $3.15 and a twelve month high of $3.31. The business has a 50-day moving average of $3.34 and a 200 day moving average of $3.93.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.

In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.